EODData

FRA, UQ1: uniQure N.V

02 Jul 2026
LAST:

39.95

CHANGE:
 1.50
OPEN:
39.95
HIGH:
39.95
ASK:
0.00
VOLUME:
0
CHG(%):
3.62
PREV:
41.45
LOW:
39.95
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
02 Jul 2639.9539.9539.9539.950
30 Jun 2641.5041.5041.4541.450
29 Jun 2641.5042.7041.3041.30951
25 Jun 2643.4543.9043.4543.900
24 Jun 2643.0043.0042.6042.60100
23 Jun 2638.7538.7538.7538.750
22 Jun 2640.4040.7540.4040.750
18 Jun 2641.9543.4540.0040.550
17 Jun 2623.3541.1523.3541.15225
16 Jun 2624.2524.2524.2524.250

PROFILE

Name:uniQure N.V
About:uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Sector:Healthcare
Industry:Biotechnology
Address:Paasheuvelweg 25, Amsterdam, Netherlands, 1105 BP
Website:https://www.uniqure.com
ISIN:NL0010696654

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-4.27 
Forward P/E:-15.90 
PEG Ratio:-0.08 
Price to Sales:83.01 
Price to Book:6.72 
Profit Margin:0.32 
Operating Margin:-13.30 
Return on Assets:-0.14 
Return on Equity:-1.65 
Revenue:13.38M 
Shares:54.87M 
Market Cap:2.192B 

TECHNICAL INDICATORS

MA5:41.844.7%
MA10:39.471.2%
MA20:31.5726.6%
MA50:24.3364.2%
MA100:19.90100.7%
MA200:24.4263.6%
STO9:23.30
STO14:81.46 
RSI14:76.02 
WPR14:-18.54 
MTM14:17.35
ROC14:0.77 
ATR:2.59 
Week High:43.909.9%
Week Low:39.950.0%
Month High:43.909.9%
Month Low:22.6063.6%
Year High:60.5051.4%
Year Low:7.26450.1%
Volatility:8.21